Viewing Study NCT07215559


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2026-01-21 @ 1:01 AM
Study NCT ID: NCT07215559
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-10-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module